期刊文献+

温经通络方防治奥沙利铂致周围神经毒性的临床护理观察 被引量:5

下载PDF
导出
摘要 目的探讨温经通络方防治奥沙利铂化疗后的周围神经毒性反应的效果。方法将90例以奥沙利铂化疗的食管癌、胃癌、结直肠癌患者随机分为治疗组和对照组,各45例。对照组按常规护理预防,治疗组在常规护理的基础上采用温经通络方洗/浸上、下肢。2周为一疗程,两组治疗均不少于6个周期。观察每周期治疗后外周神经毒性的发生率。结果第1~2疗程后治疗组与对照组神经毒性发生率分别为15.56%vs.24.44%(P=0.292),20.00%vs.31.11%(P=0.227),两组差异无统计学意义;同时秩和检验亦提示两组神经毒性的严重程度差异无统计学意义,P值分别为0.2996,0.2351。第3~6疗程后治疗组与对照组神经毒性发生率分别为26.67%vs.48.89%(P=0.030),31.11%vs.62.22%(P=0.003),35.56%vs.71.11%(P=0.001),42.22%vs.80.00%(P=0.000),两组差异有统计学意义;同时秩和检验亦提示两组神经毒性严重程度差异有统计学意义,P值分别为0.022,0.001,0.000和0.000。结论通过温经通络方和细致的常规护理措施能够有效降低奥沙利铂化疗后的周围神经毒性反应,值得在临床推广。
机构地区 广东省中医院
出处 《临床医学工程》 2010年第12期102-103,共2页 Clinical Medicine & Engineering
  • 相关文献

参考文献10

二级参考文献28

  • 1孔颖泽,徐珍,冷嘉兴.黄芪桂枝五物汤加减治疗奥沙利铂所致神经毒性的体会[J].河北中医,2005,27(12):923-924. 被引量:24
  • 2宁莉.中药治疗奥沙利铂神经毒性16例[J].辽宁中医杂志,2006,33(1):63-63. 被引量:16
  • 3胡发明.奥沙利铂的不良反应和安全性[J].国外医药合成药·生化药·制剂分册,1999,20(3):184-185.
  • 4周际昌.实用中瘤内科学[M](第2版)[M].北京:人民卫生出版社,2003,4..
  • 5Kelly H, Goldberg RM. Systemic therapy for metastatic colorectal cancer: current options, current evidence [ J]. J Clin Oncol, 2005, 23 (20) : 4553-4560.
  • 6Aggarwal S, Chu E. Current therapies for advanced colorectal cancer [J]. Oncology (Williston Park), 2005, 19(5): 589-595.
  • 7Markman M. Toxicities of the platinum antineoplastic agents [J]. Expert Opin Drug Saf, 2003, 2(6) : 597-607.
  • 8Cassidy J, Misset JL. Oxaliplatin-related side effects: characteristics and management [ J ] . Semin Oncol, 2002, 29 (5 Suppl 15 ) : 11-20.
  • 9Levi F, Misset JL, Brienza S, et al. A chronopharmacologic phase Ⅱ clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory muhichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer [ J ]. Cancer, 1992, 69 (4) : 893-900.
  • 10Levi F, Misset JL, Brienza S, et al. A chronopharmacologic phase Ⅱ clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. Highantitumor effectiveness against metastatic colorectal cancer[J]. Cancer,1992,69(4):893-900.

共引文献150

同被引文献69

  • 1李倩,郭伟剑,郑磊贞.奥沙利铂的神经毒性和防治进展[J].上海交通大学学报(医学版),2006,26(4):430-433. 被引量:50
  • 2叶豆丹,丁涛,徐惠波,孙晓波,刘丹.人参四逆汤不同部分提取物对微循环的影响[J].吉林中医药,2007,27(5):54-55. 被引量:5
  • 3Cassidy J,M isset JL.Oxaliplatin-related side effects:charac-teristics and management[J].Semin Oncol,2002,29(5 Suppl15):11-20.
  • 4孙燕.抗癌药物急性与亚急性毒性反应分度标准临床肿瘤手册[M].5版.北京:人民卫生出版社,2005:145.
  • 5Grothey A.Oxaliplatin-safty Profile:Neurotoxicity[J].Semin Oncol,2003,30(4 Suppl 15):5-13.
  • 6Krishnan AV, Goldstein D, Friedlander M, et al.Oxaliplatin induced neurotoxicity and the development of neuropathy[ J ] .Mu- scle Nerve, 2005,32 ( 4 ) : 51-60.
  • 7Michael DStubblefield, Margaret LMcNeely, Catherine MAlfano. A Prospective Surveillance Model for Physical Rehabilitation of Women With Breast Cancer[ J ] .Neuropathy in Breast Cancer, 2012,118 ( 8 ): 2250-2260.
  • 8钱一丹.中药浸泡治疗紫杉醇所致外周神经毒性反应疗效观察及护理[J].浙江中医药大学学报,2011,35(1):119-120.
  • 9Jernal A, Bray F, Center M M, et al.Global cancer statistics[J].CA CancerJClin, 2011, 61(2): 69-90.
  • 10Andre T, Boni C, Mounedji-Boudiaf L, et al.For the Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer(MOSAIC) Investigators.Oxaliplatin, fluorouracil, and leueovorin as adjuvant treatment for colon eancer[J].N Engl J Med, 2004, 350(23): 2343-2351.

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部